Projects per year
Fingerprint
Dive into the research topics where Jonathan L Vennerstrom is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 6 Finished
-
-
-
Increasing the Antischistosomal Selectivity of Aryl Hydantoins
8/15/12 → 7/31/15
Project: Research project
-
-
Research Output
-
A new chemotype with promise against Trypanosoma cruzi
Wang, X., Cal, M., Kaiser, M., Buckner, F. S., Lepesheva, G. I., Sanford, A. G., Wallick, A. I., Davis, P. H. & Vennerstrom, J. L., Jan 1 2020, In: Bioorganic and Medicinal Chemistry Letters. 30, 1, 126778.Research output: Contribution to journal › Article › peer-review
-
Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-Acridanone hydrazone
Probst, A., Häberli, C., Siegel, D., Huang, J., Vigneron, S., Ta, A. P., Skinner, D. E., El-Sakkary, N., Momper, J. D., Gangoiti, J., Dong, Y., Vennerstrom, J. L., Charman, S. A., Caffrey, C. R. & Keiser, J., Oct 1 2020, In: Journal of Antimicrobial Chemotherapy. 75, 10, p. 2925-2932 8 p.Research output: Contribution to journal › Article › peer-review
-
Ligand-based design of GLUT inhibitors as potential antitumor agents
Almahmoud, S., Jin, W., Geng, L., Wang, J., Wang, X., Vennerstrom, J. L. & Zhong, H. A., Apr 1 2020, In: Bioorganic and Medicinal Chemistry. 28, 7, 115395.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids
Wu, J., Wang, X., Chiu, F. C. K., Häberli, C., Shackleford, D. M., Ryan, E., Kamaraj, S., Bulbule, V. J., Wallick, A. I., Dong, Y., White, K. L., Davis, P. H., Charman, S. A., Keiser, J. & Vennerstrom, J. L., Apr 9 2020, In: Journal of Medicinal Chemistry. 63, 7, p. 3723-3736 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67
Alshammari, A. M., Smith, D. D., Parriott, J., Stewart, J. P., Curran, S. M., McCulloh, R. J., Barry, P. A., Iyer, S. S., Palermo, N., Phillips, J. A., Dong, Y., Ronning, D. R., Vennerstrom, J. L., Sanderson, S. D. & Vetro, J. A., May 8 2020, In: ACS infectious diseases. 6, 5, p. 1169-1181 13 p.Research output: Contribution to journal › Article › peer-review